| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1038/MODPATHOL.2010.147 |
| P698 | PubMed publication ID | 21455198 |
| P2093 | author name string | Vânia Nosé | |
| P2860 | cites work | Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. | Q27851420 |
| PTEN: one gene, many syndromes | Q28203387 | ||
| Cancer phenomics: RET and PTEN as illustrative models | Q28278854 | ||
| Early Malignant Progression of Hereditary Medullary Thyroid Cancer | Q30320549 | ||
| Familial thyroid cancer | Q30624270 | ||
| The Werner syndrome. A model for the study of human aging. | Q30888392 | ||
| A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns] | Q31942209 | ||
| Solitary, multiple, and familial oxyphil tumours of the thyroid gland | Q33598398 | ||
| Familial non-medullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families | Q33723630 | ||
| Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21 | Q34044355 | ||
| Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment | Q34064449 | ||
| Familial nonmedullary thyroid neoplasia | Q34387003 | ||
| A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. | Q34388217 | ||
| PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome | Q34504165 | ||
| Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer | Q35249940 | ||
| Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study | Q35754648 | ||
| Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee | Q36009325 | ||
| Familial nonmedullary thyroid carcinoma | Q36493217 | ||
| Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. | Q36720274 | ||
| Familial non-medullary thyroid carcinoma: an update | Q37302842 | ||
| Familial thyroid carcinoma: a diagnostic algorithm | Q37307434 | ||
| Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer | Q37650501 | ||
| Familial nonmedullary thyroid cancer: a review of the genetics | Q37750895 | ||
| Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas | Q38480240 | ||
| Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. | Q40458573 | ||
| Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm | Q40495414 | ||
| The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis | Q40920116 | ||
| Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease | Q41091439 | ||
| Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems | Q41722801 | ||
| The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome | Q43075651 | ||
| Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene | Q44243688 | ||
| Does familial non-medullary thyroid cancer adversely affect survival? | Q44696753 | ||
| Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation | Q45345194 | ||
| Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series | Q46196359 | ||
| Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma | Q47706781 | ||
| Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes | Q47809715 | ||
| Familial risks for nonmedullary thyroid cancer | Q48708770 | ||
| A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer. | Q51803176 | ||
| Mutational analysis of the APC gene in cribriform-morula variant of papillary thyroid carcinoma. | Q51806465 | ||
| The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. | Q53660179 | ||
| A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma | Q55670928 | ||
| A Comprehensive Analysis ofMNG1,TCO1,fPTC,PTEN,TSHR, and TRKA in Familial Nonmedullary Thyroid Cancer: Confirmation of Linkage to TCO1 | Q57320043 | ||
| Carney Complex, Peutz-Jeghers Syndrome, Cowden Disease, and Bannayan-Zonana Syndrome Share Cutaneous and Endocrine Manifestations, But Not Genetic Loci | Q57320090 | ||
| At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family | Q57610575 | ||
| Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior | Q57648324 | ||
| Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas | Q59482725 | ||
| Familial Nonmedullary Thyroid Cancer | Q61346300 | ||
| Familial medullary thyroid carcinoma and C cell hyperplasia | Q70938789 | ||
| Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities | Q71046691 | ||
| Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment | Q71113168 | ||
| Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid | Q73047731 | ||
| Thyroid Gland Abnormalities in Patients with the Syndrome of Spotty Skin Pigmentation, Myxomas, Endocrine Overactivity, and Schwannomas (Carney Complex) | Q73493467 | ||
| Familial papillary thyroid microcarcinoma: a new clinical entity | Q74464571 | ||
| Unusual features of thyroid carcinomas in Japanese patients with Werner syndrome and possible genotype-phenotype relations to cell type and race | Q77214203 | ||
| Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli | Q77351682 | ||
| RET protooncogene analysis in the diagnosis of medullary thyroid carcinoma and multiple endocrine neoplasia type II | Q77735037 | ||
| Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population | Q77978310 | ||
| Difference between familial and sporadic medullary thyroid carcinomas | Q78841561 | ||
| Case records of the Massachusetts General Hospital. Case 37-2006. A 19-year-old woman with thyroid cancer and lower gastrointestinal bleeding | Q79393973 | ||
| Simultaneous occurrence of medullary carcinoma and papillary microcarcinoma of thyroid in a patient with MEN 2A syndrome. report of a case | Q80208791 | ||
| Familial nonmedullary thyroid cancer | Q80392288 | ||
| On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds | Q83153091 | ||
| Increasing incidence of thyroid cancer in the United States, 1973-2002 | Q83310394 | ||
| P921 | main subject | thyroid cancer | Q826522 |
| P304 | page(s) | S19-33 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Modern Pathology | Q15724578 |
| P1476 | title | Familial thyroid cancer: a review | |
| P478 | volume | 24 Suppl 2 |
| Q30367068 | 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer |
| Q40182145 | A Papillary Thyroid Tumor Detected by (18)F-FDG-PET/CT in a Pediatric Patient with Cowden Syndrome. |
| Q90622953 | A unique case of two somatic APC mutations in an early onset cribriform-morular variant of papillary thyroid carcinoma and overview of the literature |
| Q93081074 | Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer |
| Q28274820 | Diagnosis and Management of Hereditary Thyroid Cancer |
| Q33839037 | Differentiated Thyroid Cancer-Treatment: State of the Art. |
| Q55491526 | Educational Case: Endocrine Neoplasm: Medullary Thyroid Carcinoma. |
| Q27348342 | Emerging integrated nanoclay-facilitated drug delivery system for papillary thyroid cancer therapy |
| Q37794008 | Familial Follicular Cell Tumors: Classification and Morphological Characteristics |
| Q42093605 | Familial Non-Medullary Thyroid Cancer Represents an Independent Risk Factor for Increased Cancer Aggressiveness: A Retrospective Analysis of 74 Families |
| Q39257903 | Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period. |
| Q35971943 | Familial follicular cell-derived thyroid carcinoma |
| Q33589733 | Familial multinodular goiter syndrome with papillary thyroid carcinomas: mutational analysis of the associated genes in 5 cases from 1 Chinese family |
| Q35449938 | Familial papillary thyroid carcinoma: a retrospective analysis |
| Q54338447 | Family Screening in Familial Papillary Carcinoma: The Early Detection of Thyroid Disease. |
| Q38261984 | Genetic predisposition for nonmedullary thyroid cancer |
| Q94948533 | Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden |
| Q48120117 | Hereditary and familial thyroid tumours |
| Q33716534 | Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition |
| Q38683133 | Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases |
| Q52666449 | Medullary thyroid cancer, leukemia, mesothelioma and meningioma associated with germline APC and RASAL1 variants: a new syndrome? |
| Q64927943 | Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells. |
| Q50134829 | Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions. |
| Q38165028 | Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES). |
| Q88125745 | Outcome of Treatment for Medullary Thyroid Carcinoma-a Single Centre Experience |
| Q88630642 | Pancreatic adenocarcinoma with a germline PTEN p.Arg234Gln mutation |
| Q41617267 | Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer |
| Q51250971 | Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. |
| Q31158779 | Role of genetic variants of autophagy genes in susceptibility for non-medullary thyroid cancer and patients outcome |
| Q36276087 | Running in the family: A rare diagnosis of familial papillary thyroid cancer |
| Q47940168 | Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype |
| Q38883187 | Targeted Therapies in Thyroid Cancer: An Extensive Review of the Literature |
| Q35978629 | The clinical management in familial adenomatous polyposis deserves continuous monitoring for thyroid carcinoma |
| Q38937305 | The impact of family history on non-medullary thyroid cancer. |
| Q42032113 | Thyroid cancer: The thyroid cancer epidemic - overdiagnosis or a real increase? |
| Q37591712 | Thyroid: Medullary Carcinoma |
| Q34729785 | Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetrance |
Search more.